<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0DC62C57-557C-41C1-B61E-CA2BAA41BDE1"><gtr:id>0DC62C57-557C-41C1-B61E-CA2BAA41BDE1</gtr:id><gtr:name>Ragon Institute of MGH, MIT and Harvard</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DE956CB8-1DF4-49EB-BC34-78BD6095649A"><gtr:id>DE956CB8-1DF4-49EB-BC34-78BD6095649A</gtr:id><gtr:name>University of KwaZulu-Natal</gtr:name><gtr:address><gtr:line1>Govan Mbeki Centre</gtr:line1><gtr:line2>Westville Campus</gtr:line2><gtr:line3>Private Bag X54001</gtr:line3><gtr:postCode>4000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C"><gtr:id>FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C</gtr:id><gtr:name>University of Alabama at Birmingham</gtr:name><gtr:address><gtr:line1>1720 2nd Avenue South</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:line5>Alabama 35294-0017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D6066EF-3116-4DB9-A313-EA86A562F928"><gtr:id>5D6066EF-3116-4DB9-A313-EA86A562F928</gtr:id><gtr:name>Imperial College Healthcare NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0DC62C57-557C-41C1-B61E-CA2BAA41BDE1"><gtr:id>0DC62C57-557C-41C1-B61E-CA2BAA41BDE1</gtr:id><gtr:name>Ragon Institute of MGH, MIT and Harvard</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DE956CB8-1DF4-49EB-BC34-78BD6095649A"><gtr:id>DE956CB8-1DF4-49EB-BC34-78BD6095649A</gtr:id><gtr:name>University of KwaZulu-Natal</gtr:name><gtr:address><gtr:line1>Govan Mbeki Centre</gtr:line1><gtr:line2>Westville Campus</gtr:line2><gtr:line3>Private Bag X54001</gtr:line3><gtr:postCode>4000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C"><gtr:id>FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C</gtr:id><gtr:name>University of Alabama at Birmingham</gtr:name><gtr:address><gtr:line1>1720 2nd Avenue South</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:line5>Alabama 35294-0017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D6066EF-3116-4DB9-A313-EA86A562F928"><gtr:id>5D6066EF-3116-4DB9-A313-EA86A562F928</gtr:id><gtr:name>Imperial College Healthcare NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BAB65FFE-E604-42EE-9732-FEB0B30C6D6C"><gtr:id>BAB65FFE-E604-42EE-9732-FEB0B30C6D6C</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Prendergast</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500384"><gtr:id>B1E5209D-62B8-4E66-ACB3-3196A1AE4C6D</gtr:id><gtr:title>Factors influencing immunodominance of the cytotoxic T lymphocyte response in C clade HIV infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0500384</gtr:grantReference><gtr:abstractText>The immune response plays a central role in influencing the rate of progression to HIV disease. The particular immune cells critical in the immune response against HIV are termed cytotoxic T lymphocytes (CTL). These cells can recognise fragments of HIV proteins presented on the surface of infected cells. In this way CTL can recognise and kill HIV-infected cells. 
These investigators have, since 1998, studied the CTL response against HIV in South Africa, an epicentre of the epidemic. Recently published studies by this group highlighted the dominant role of particular CTL, which play the major part in influencing disease outcome. However, whilst certain CTL are associated with slow progression to HIV disease, other CTL are associated with particularly poor control of HIV.
The hypothesis underlying these proposed studies is that these differences in outcome relate principally to the particular fragments of HIV that are recognised by the CTL. The aim of this proposed research is, therefore, to determine, first, the precise identity of these fragments of HIV proteins that may play a key part in shaping the effectiveness of immune control of HIV; and, second, what are the factors that influence whether or not responses to these protein fragments are made.</gtr:abstractText><gtr:technicalSummary>The cytotoxic T lymphocyte (CTL) response against HIV plays a central role in control of viral replication and in influencing the rate of progression to HIV disease. The work of this group of investigators has since 1998 focused its efforts on characterising the anti-clade C CTL response in infected Zulu/Xhosa from Durban, South Africa, an epicentre of the epidemic. Initial analysis of the HIV-specific responses in 375 adults with chronic infection in Durban demonstrated that HLA-B alleles play the dominant role in the CTL response, in mediating selection pressure on the virus, and in influencing disease outcome. However, certain HLA-B alleles are associated with effective control, whilst other HLA-B alleles are associated with particularly poor control of HIV. 

The hypothesis underlying these proposed studies is that these differences in outcome relate principally to the specific HLA-B-restricted CTL epitopes that are targeted by individual study subjects. The aim of this proposed research is, therefore, to determine, first, what are the particular epitopes that may play a key part in shaping the efficacy of the CTL response; and, second, what are the factors that influence whether or not responses to these epitopes are initially generated and subsequently maintained.</gtr:technicalSummary><gtr:fund><gtr:end>2008-10-02</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-03</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>190666</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Alabama at Birmingham</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>University of Alabama</gtr:description><gtr:id>54993E23-6860-4A87-8378-88DECBA45DF2</gtr:id><gtr:impact>Publication:
18426987</gtr:impact><gtr:outcomeId>HMPapmzYsAg-1</gtr:outcomeId><gtr:partnerContribution>Sharing of data for publication</gtr:partnerContribution><gtr:piContribution>Sharing of viral sequencing data leading to publication</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Johns Hopkins Bloomberg School of Public Health</gtr:department><gtr:description>Zvitambo Project</gtr:description><gtr:id>565D62B9-AD79-4A51-864E-A88581B5CED9</gtr:id><gtr:impact>None yet; discussions are ongoing and projects being planned</gtr:impact><gtr:outcomeId>GngcgVzovVp-1</gtr:outcomeId><gtr:partnerContribution>The Zvitambo Project has a unique archive of clinical trial samples and we are currently formulating research ideas to explore disease progression in HIV-infected infants (using HLA typing to determine alleles associated with rapid or slow disease progression)</gtr:partnerContribution><gtr:piContribution>We have fostered a new collaboration between the University of Oxford and the Zvitambo Project, Harare, Zimbabwe. We are exploring potential collaborative projects currently.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ragon Institute of MGH, MIT and Harvard</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Boston</gtr:description><gtr:id>B31E9FAC-9AE0-42D1-B1E5-7708A516F5C6</gtr:id><gtr:impact>The following manuscripts resulted from this collaboration:
19828603
19605475
19244334
18580613 
18434400
18426987
18284325
17881456
17617274
17545701
17409157
 17251285
17173051</gtr:impact><gtr:outcomeId>L81ZNizFRE9-1</gtr:outcomeId><gtr:partnerContribution>Collaboration on studies in Durban</gtr:partnerContribution><gtr:piContribution>Study of HIV-infected infants and cohort of HIV-infected adults was established jointly between Oxford and Harvard</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College Healthcare NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Paediatric Infectious Diseases Imperial College</gtr:department><gtr:description>St Mary's Hospital, London</gtr:description><gtr:id>2E3216B6-4ABD-48A6-A7C0-0EC82A05A6BE</gtr:id><gtr:impact>Two publications (PubMed ID 21834749 and 21505296)

The collaboration involves with doctors and Clinical Nurse Specialists working in the paediatric HIV clinic</gtr:impact><gtr:outcomeId>rL1FCq6iQgx-1</gtr:outcomeId><gtr:partnerContribution>Recruitment of patients leading to research findings and publications</gtr:partnerContribution><gtr:piContribution>We established a paediatric HIV cohort to study immune responses in children, several of whom were recruited from this clinic</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Great Ormond Street Hospital (GOSH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infectious Diseases</gtr:department><gtr:description>Great Ormond Street Hospital</gtr:description><gtr:id>903845C4-68A6-4A81-91A3-D91C915480E0</gtr:id><gtr:impact>Two publications (PubMed ID 21834749 and 21505296)
The collaboration involves with doctors and Clinical Nurse Specialists working in the paediatric HIV clinic</gtr:impact><gtr:outcomeId>SG6qYXRQnAo-1</gtr:outcomeId><gtr:partnerContribution>Recruitment of patients leading to research findings and publications</gtr:partnerContribution><gtr:piContribution>We established a paediatric HIV cohort to study immune responses in children. Several children were recruited from this site.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Microbiology</gtr:department><gtr:description>Univsersity of Washington</gtr:description><gtr:id>E0072D50-AD6E-49D4-98D9-440964966B5F</gtr:id><gtr:impact>Publications:
18596105 
 18434400</gtr:impact><gtr:outcomeId>cZA4mmaZQc1-1</gtr:outcomeId><gtr:partnerContribution>Sharing of research data leading to publication</gtr:partnerContribution><gtr:piContribution>Shared viral sequencing data for use in manuscript</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of KwaZulu-Natal</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>Durban</gtr:description><gtr:id>E6BF87C5-E00D-4E77-8294-BF49BAE176B1</gtr:id><gtr:impact>The following manuscripts were published as a result of the collaboration with the Durban lab:
19828603
19605475
19244334
18580613 
18434400
18426987
18284325
17881456
17617274
17545701
17409157
 17251285
17173051</gtr:impact><gtr:outcomeId>tFyESAyfprj-1</gtr:outcomeId><gtr:partnerContribution>Establishment of an adult and paediatric HIV cohort</gtr:partnerContribution><gtr:piContribution>Collaboration on a clinical trial of treatment strategies for HIV-infected infants in Durban. Financial and academic support, plus clinical support from our team. Study run in collaboration between Boston, Durban and Oxford.

Collaboration on establishing a cohort of HIV-infected adults for studies of CTL-mediated control of HIV infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>926528</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Intermediate Clinical Fellow</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>1B5C1EB3-05A0-4D6E-911B-71E3645D57B4</gtr:id><gtr:outcomeId>qE4BkLJzATp0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Young Investigator CROI</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>Conference on Retroviruses and Opportunistic Infections (CROI)</gtr:fundingOrg><gtr:id>F2D9D7D9-54E6-4471-9827-8DCC81DBCC7C</gtr:id><gtr:outcomeId>tZJuozob4UJ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH Scholarship</gtr:description><gtr:end>2007-03-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>675BC0D1-3D84-41CE-B9FC-697185AD56F3</gtr:id><gtr:outcomeId>AievkYj1DyM0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Paediatric Guidelines 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>92427837-D9FF-4874-BEB1-74C9CE122EFD</gtr:id><gtr:impact>I was a member of the WHO guidelines group for antiretroviral treatment of HIV infection in adults, pregnant women and children, published 2013. Guidelines now recommend earlier treatment thresholds, and have extended universal treatment for children to &amp;lt;5 years of age,and extended treatment of pregnant women to all women</gtr:impact><gtr:outcomeId>KyBRChSh3AA</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Infant Treatment guidelines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>829E375B-9DB2-4A4E-AEBB-DF8ED26E9371</gtr:id><gtr:impact>As a result of data presented at the Conference on Retroviruses and Opportunistic Infections (Feb 2008), I was invited to present these data at a WHO meeting in Geneva and joined the Technical Reference Group on HIV/ART Care as a result. Discussions held at this meeting resulted in a change in international HIV treatment guidelines for infants, to recommend universal treatment of HIV-infected infants due to the impact on morbidity and mortality.</gtr:impact><gtr:outcomeId>BKEbg2t5d13</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A database of 710 clade C HIV sequences was generated as a result of work partly carried out under this grant, which has been shared with other research groups addressing questions of viral sequence change in HIV infection</gtr:description><gtr:id>C9C41D21-0F76-4F83-9680-FD74CB7A9BE1</gtr:id><gtr:impact>The following publications resulted from this database of viral sequences:
19244334
19242411
18596105
18434400
18426987
 17409157
17251285
17173051</gtr:impact><gtr:outcomeId>TZ7Yj5cd7C1</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Clade C HIV sequences</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EF18A22A-0180-4A31-A9F9-A025AE8C9096</gtr:id><gtr:title>Immunity to HIV in Early Life.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17f561bb54c2cb889420f73cc138ae78"><gtr:id>17f561bb54c2cb889420f73cc138ae78</gtr:id><gtr:otherNames>Muenchhoff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5464786bb2c2d8.93406385</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE7A0D36-476A-4390-A59B-500C5B9A5343</gtr:id><gtr:title>Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3164abe52910f05ccfe8826fc886f6c9"><gtr:id>3164abe52910f05ccfe8826fc886f6c9</gtr:id><gtr:otherNames>Prendergast A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>iLRw6V8YtAR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0EE83B5-6968-45ED-8697-E5D24A15E803</gtr:id><gtr:title>The impact of differential antiviral immunity in children and adults.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe867304a2afe0453c28f658bc7e187c"><gtr:id>fe867304a2afe0453c28f658bc7e187c</gtr:id><gtr:otherNames>Prendergast AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>pm_14834_24_22918466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3977E65E-245B-41AB-9643-5A84647D9531</gtr:id><gtr:title>CD8+ T-cell responses to different HIV proteins have discordant associations with viral load.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fcba991cefb6af3a5dd59220039ddf0"><gtr:id>7fcba991cefb6af3a5dd59220039ddf0</gtr:id><gtr:otherNames>Kiepiela P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>QCqJS35Ne6W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D321253D-AB3C-437C-B585-F143787AF4C0</gtr:id><gtr:title>Factors influencing T cell activation and programmed death 1 expression in HIV-infected children.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3164abe52910f05ccfe8826fc886f6c9"><gtr:id>3164abe52910f05ccfe8826fc886f6c9</gtr:id><gtr:otherNames>Prendergast A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn><gtr:outcomeId>G9fyfuteTAq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA89FFAC-BE3F-46CB-B338-EF25CDFA9A5F</gtr:id><gtr:title>Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/071aa867a6d96e08f6398d3074b97da1"><gtr:id>071aa867a6d96e08f6398d3074b97da1</gtr:id><gtr:otherNames>Goepfert PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>U5b3VxQzVH7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B4B20B9-5D40-465A-81FB-1FB9AADE3F7A</gtr:id><gtr:title>International perspectives, progress, and future challenges of paediatric HIV infection.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3164abe52910f05ccfe8826fc886f6c9"><gtr:id>3164abe52910f05ccfe8826fc886f6c9</gtr:id><gtr:otherNames>Prendergast A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>VcgZ9kzrLJh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8797E4E-5F82-46E9-A142-B43CBC817901</gtr:id><gtr:title>Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/670e161ddb05e002f852b23130851c16"><gtr:id>670e161ddb05e002f852b23130851c16</gtr:id><gtr:otherNames>Frater AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>AwXvXXt8ibp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>538FE2EE-1BA7-4F7C-AD12-60A56807A736</gtr:id><gtr:title>Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81959f2a0b1cc2014169164ebdc5f383"><gtr:id>81959f2a0b1cc2014169164ebdc5f383</gtr:id><gtr:otherNames>Adland E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56e0315da1b552.64076425</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23A3A34D-EB0D-4EE4-9413-362AE2D227D4</gtr:id><gtr:title>Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fb25d83715c29e0eaf7b3a566c436ba"><gtr:id>0fb25d83715c29e0eaf7b3a566c436ba</gtr:id><gtr:otherNames>Matthews PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>i1UGc9sPRvc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C32CE6A3-9AEA-4BF4-BDE8-211813C8E85B</gtr:id><gtr:title>Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fde58517e2d210ae87b04c55321a6a73"><gtr:id>fde58517e2d210ae87b04c55321a6a73</gtr:id><gtr:otherNames>Prado JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>YwAKn4DnYbb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>732189AB-7B32-425E-9809-E3F2B376BE87</gtr:id><gtr:title>HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3164abe52910f05ccfe8826fc886f6c9"><gtr:id>3164abe52910f05ccfe8826fc886f6c9</gtr:id><gtr:otherNames>Prendergast A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>gfswJr5pRRq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5AF8DCC-8EE2-43CC-BB1C-C7473992C0BC</gtr:id><gtr:title>Short communication: CD8(+) T cell polyfunctionality profiles in progressive and nonprogressive pediatric HIV type 1 infection.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10e203d0a7524b1de57bf6bb9c17a2f6"><gtr:id>10e203d0a7524b1de57bf6bb9c17a2f6</gtr:id><gtr:otherNames>Thobakgale CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn><gtr:outcomeId>Yxj6UW4PoBv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF8AFC84-1BD6-4689-B3E1-B46BBD361A54</gtr:id><gtr:title>Approaches towards avoiding lifelong antiretroviral therapy in paediatric HIV infection.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6027f30e476e2d3937af0b3f34b92eb5"><gtr:id>6027f30e476e2d3937af0b3f34b92eb5</gtr:id><gtr:otherNames>Goulder PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>JDsow3ZE1qR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75999D2A-6AFF-4FD7-BF50-C8370F0539FD</gtr:id><gtr:title>HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fb25d83715c29e0eaf7b3a566c436ba"><gtr:id>0fb25d83715c29e0eaf7b3a566c436ba</gtr:id><gtr:otherNames>Matthews PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>TyDKRXjKLjR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7318829-CA05-41CD-AF5C-1AB7905FFAA6</gtr:id><gtr:title>Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10e203d0a7524b1de57bf6bb9c17a2f6"><gtr:id>10e203d0a7524b1de57bf6bb9c17a2f6</gtr:id><gtr:otherNames>Thobakgale CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>CmPKvSpBbhW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A710390-4FFC-4984-9ADE-F3E853E24D70</gtr:id><gtr:title>Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17f561bb54c2cb889420f73cc138ae78"><gtr:id>17f561bb54c2cb889420f73cc138ae78</gtr:id><gtr:otherNames>Muenchhoff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>58c80ed2bcb4e9.24912185</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62B04634-276F-4902-8340-1A5F83E9F2B4</gtr:id><gtr:title>High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce5d94df3ff2e1171f1ae2a13ec3fc71"><gtr:id>ce5d94df3ff2e1171f1ae2a13ec3fc71</gtr:id><gtr:otherNames>Mphatswe W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>kobxtoemXAf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F91CFAD0-95BE-40A3-BEA0-3865F6377A3C</gtr:id><gtr:title>Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e71e435ee193f5c5787b32226caf7061"><gtr:id>e71e435ee193f5c5787b32226caf7061</gtr:id><gtr:otherNames>Mori M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e0315d720936.36117160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2A3E6B0-EA76-4E92-8364-3A6346114EC0</gtr:id><gtr:title>Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3164abe52910f05ccfe8826fc886f6c9"><gtr:id>3164abe52910f05ccfe8826fc886f6c9</gtr:id><gtr:otherNames>Prendergast A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>A34h8nfUgN7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>735AD68C-F28A-4D77-9651-9876D8DFC85B</gtr:id><gtr:title>Detection of HIV type 1 gag-specific CD4(+) T cell responses in acutely infected infants.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b1f2b362f0bab929fc3137b3dab7ed1"><gtr:id>0b1f2b362f0bab929fc3137b3dab7ed1</gtr:id><gtr:otherNames>Ramduth D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn><gtr:outcomeId>QLqMT3pnEDZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B54F066-D6A0-4DC2-A9E8-00D3D640ACCE</gtr:id><gtr:title>HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae91bb906a4bdb54c927f43d3cfff945"><gtr:id>ae91bb906a4bdb54c927f43d3cfff945</gtr:id><gtr:otherNames>Rousseau CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>F7bAs17fu1m</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93D5699D-0046-4150-934A-B0B7457606AF</gtr:id><gtr:title>Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61bd037264be4879efa8c73ec0f96925"><gtr:id>61bd037264be4879efa8c73ec0f96925</gtr:id><gtr:otherNames>Honeyborne I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pGt67VzqYHZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E33016F0-1E39-491C-9A74-3D662B2D9003</gtr:id><gtr:title>Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10e203d0a7524b1de57bf6bb9c17a2f6"><gtr:id>10e203d0a7524b1de57bf6bb9c17a2f6</gtr:id><gtr:otherNames>Thobakgale CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>Mg7wHtGp3QD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D35682E3-ABD3-4539-8350-231D54AA531C</gtr:id><gtr:title>Adaptation of HIV-1 to human leukocyte antigen class I.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99f9638246ae93c3412e8a61dc7cec4"><gtr:id>d99f9638246ae93c3412e8a61dc7cec4</gtr:id><gtr:otherNames>Kawashima Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>i29NL6EMyyd</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500384</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>